Virtual Program

Accreditation Statements

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by Canadian Association of Pathologists.  You may claim a maximum of 17.5 hours.  Credits are automatically calculated.

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Association of Pathologists. You may claim a maximum of 3.5 hours.  Credits are automatically calculated.

There are 8 sessions with SAQs.  Each questions is considered 10 minutes of assessment for a total of 3.5 hours in Section 3.  To qualify for Section 3 credits, participants must complete the pre-test, attend the course and complete the post test.

Earn Up to 3.5 Hours Section 3

Complete the pre and post test and participate in the Banff Course to qualify for Section 3 MOC.

This program is in Mountain Time/Alberta (not Eastern Time (Toronto)!)

Wed. Sept 8

Wednesday - Resident Leadership
0900-1330 Resident Leadership Focus Day
0900-1100: Informatics & Data Management** - Speakers: Chris Naugler, Etienne Mahe (Mole & GP), Susan Nahirniak (HemeP & Transfusion) & David Beyer (GP Grad - Susan is his fellowship director)
Includes: Resident research or research methodologies, data management, Connect Care or AHS
1100-1130: Break
1130-1330: Quality Assurance/ assessment / PSQA

Thurs. Sept 9

Thursday - Lymph Node Pathology

0800-0815 Introductory Remarks & Welcome
Dr. Michael Mengel (University of Alberta)
Dr. Hallgrimur Benediktsson (University of Calgary
)

Session 1 – Moderator: Dr. Meer-Taher Shabani-Rad (University of Calgary)

0815-0900 Keynote - Updates in WHO Classification of B-cell Lymphoma: A Practical Perspective
Dr. Megan Lim (University of Pennsylvania)
0900-0930 Diagnosis and Workup of Aggressive B-cell Lymphomas
Dr. Megan Lim (University of Pennsylvania)
0930-1000 New Era of Core Lymph Node Biopsies: Review of the New Alberta Health Services Protocol *Section 3 Accredited Activity with Pre & Post Tests*
Dr. Doug Stewart (University of Calgary)
1000-1030 Break

Session 2 – Moderator: Dr. Iwona Auer (University of Calgary)

1030-1100 Lymphoma Diagnosis in the Era of Needle Core Biopsies: Challenges and Pitfalls
Dr. Megan Lim (University of Pennsylvania)
1100-1130 Splenic B cell lymphoma diagnosis
Dr. Nathanael Bailey, University of Pittsburgh
1130-1200 Discussion and Question & Answer Period
1200-1400 Practical Approach to the Diagnosis of T Cell Lymphoma
Dr. Jonathan Said (University of California Los Angeles)

Session 3 – Moderator: Dr. Adnan Mansoor (University of Calgary)

1400-1430 Updates in Pediatric Lymphoma
Dr. Megan Lim (University of Pennsylvania)
1430-1500 Infectious Diseases In Lympohreticular Pathology *Section 3 Accredited Activity with Pre & Post Tests*
Dr. Gareth Turner (University of Oxford)
1500-1530 Break

Session 4 – Moderator: Dr. Afshin Shameli (University of Calgary)

1530-1615

Division of Hematopathology Case Presentations (3 cases, 15 minutes/case) *Section 3 Accredited Activity with Pre & Post Tests*
Thane Kubik - A Tale Of Hematolymphoid Distant Cousins

1615-1700 Keynote - Diagnostic Pitfalls in Lymphoma Diagnosis
Dr. Jonathan Said (University of California Los Angeles)

Fri. Sept 10

Friday - Molecular Pathology
0800-0815 Introductory Remarks & Welcome
Dr. Michael Mengel (University of Alberta)
Dr. Hallgrimur Benediktsson (University of Calgary)

Session 1 – Moderator: Dr. Faisal Khan (University of Calgary)

0815-0900 Keynote - New Developments in Molecular Testing of Lymphoma
Dr. Nathanael Bailey, University of Pittsburgh
0900-0930 Improving the Molecular Characterization of Myeloid Neoplasms
Dr. Etienne Mahe (University of Calgary)
0930-1000 Immunogenetic Landscape of Hematological Malignancies and Hematopoietic Stem Cell Transplantation *Section 3 Accredited Activity with Pre & Post Tests*
Dr. Faisal Khan (University of Calgary)
1000-1030 Break

Session 2 – Moderator: Dr. Etienne Mahe (University of Calgary)

1030-1100 Role of Surgical Pathologist in Molecular Diagnostic Testing *Section 3 Accredited Activity with Pre & Post Tests*
Dr. Iyare Izevbaye (University of Alberta)
1100-1130 NA Mismatch Repair and Microsatellite Instability: Practical Considerations in Molecular Testing of Colorectal Tumors *Section 3 Accredited Activity with Pre & Post Tests*
Dr. Cheryl Mather (University of Alberta)
1130-1200 Testing for BRCA1/2 and Homologous Recombination Deficiency in Ovarian Cancer: Standard of Care
Dr. Soufiane El-Hallani (University of Alberta)
1200-1230 Cancer Cytogenomics
Dr. Bob Argiropoulos (University of Calgary)

Session 3 – Moderator: Dr. Cheryl Mather (University of Alberta)

1230-1300 Integrating Pathology and Molecular Diagnostics for Pulmonary Neoplasms *Section 3 Accredited Activity with Pre & Post Tests*
Dr. Adrian Box (University of Calgary)
Dr. Angela Franko (University of Calgary)
1300-1400 Molecular Testing of Cytology Specimens *Section 3 Accredited Activity with Pre & Post Tests*
Dr. Remegio Maglantay (University of Alberta)

Sat. Sept 11

Saturday - Molecular Pathology, Genetics & Genomics

0800-0815 Introductory Remarks & Welcome
Dr. Michael Mengel (University of Alberta)
Dr. Hallgrimur Benediktsson (University of Calgary
)

Session 1 – Moderator: Dr. Imran Mirza (University of Calgary)

0815-0900 Discussion Forum
Molecular Pathology/Genomics Education Opportunities for Residents and Pathologists
Dr. Adrian Box (University of Calgary) – Moderator
Dr. Jillian Parboosingh (University of Calgary)
Dr. Dennis Bulman (University of Calgary)
0900-0930 Molecular autopsies in sudden death cases: a multi-discipline approach to implementing NGS testing for Inherited Cardiac Disorders
Dr. Sherry Taylor (University of Alberta)
0930-1000 Direct to Consumer Genetic Testing: Issues and Challenges
Dr. Jillian Parboosingh (University of Calgary)

Session 2 – Moderator: Dr. Iyare Izevbaye (University of Alberta)

1000-1015 Break
1015-1130 Ethical Considerations in Testing and Reporting in Molecular Genetic Pathology
Dr. Dennis Bulman (University of Calgary)
1130-1200 Interpreting Molecular Genetic Pathology Reports
Dr. Imran Mirza (University of Calgary)
1200-1215 Closing Remarks
Dr. Michael Mengel (University of Alberta)
Dr. Hallgrimur Benediktsson (University of Calgary
)